FR2313915B1 - - Google Patents

Info

Publication number
FR2313915B1
FR2313915B1 FR7601947A FR7601947A FR2313915B1 FR 2313915 B1 FR2313915 B1 FR 2313915B1 FR 7601947 A FR7601947 A FR 7601947A FR 7601947 A FR7601947 A FR 7601947A FR 2313915 B1 FR2313915 B1 FR 2313915B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7601947A
Other languages
French (fr)
Other versions
FR2313915A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7601947A priority Critical patent/FR2313915A1/en
Publication of FR2313915A1 publication Critical patent/FR2313915A1/en
Application granted granted Critical
Publication of FR2313915B1 publication Critical patent/FR2313915B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
FR7601947A 1976-01-26 1976-01-26 Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating Granted FR2313915A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7601947A FR2313915A1 (en) 1976-01-26 1976-01-26 Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7601947A FR2313915A1 (en) 1976-01-26 1976-01-26 Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating

Publications (2)

Publication Number Publication Date
FR2313915A1 FR2313915A1 (en) 1977-01-07
FR2313915B1 true FR2313915B1 (en) 1980-06-13

Family

ID=9168343

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7601947A Granted FR2313915A1 (en) 1976-01-26 1976-01-26 Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating

Country Status (1)

Country Link
FR (1) FR2313915A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906145B2 (en) 2002-04-09 2011-03-15 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
US7910133B2 (en) 2002-04-09 2011-03-22 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
US8084045B2 (en) 2003-11-21 2011-12-27 Flamel Technologies Pharmaceutical formulations for the prolonged release of active principle(s) and their applications
CN1681483B (en) * 2002-07-26 2011-12-28 弗拉梅技术公司 Improved oral microcapsule with low-solubility active component
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432313A1 (en) * 1978-08-01 1980-02-29 Foulhoux Pierre Micro:granules contg. beta-histine - for controlled release and less side effects useful in treating Menieres syndrome
SE7813246L (en) * 1978-12-22 1980-06-23 Haessle Ab FIXED PHARMACEUTICAL PREPARATION INCLUDING BODIES WITH MULTIPLE LAYERS
JPS5762277A (en) * 1980-06-23 1982-04-15 Ciba Geigy Ag Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine
FR2492661A1 (en) * 1980-10-28 1982-04-30 Laruelle Claude NOVEL GALENIC FORM OF ADMINISTRATION OF METOCLOPRAMIDE, ITS PREPARATION METHOD AND MEDICINAL PRODUCT COMPRISING THIS NOVEL FORM
FR2494112B1 (en) * 1980-11-19 1986-01-10 Laruelle Claude
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
GB2159715B (en) * 1984-06-04 1988-05-05 Sterwin Ag Pharmaceutical composition in sustained release unit dose form and process for its preparation
IT1204839B (en) * 1986-03-14 1989-03-10 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS CONTAINING VINBURNIN AND THEIR PREPARATION PROCEDURE
FR2842736B1 (en) 2002-07-26 2005-07-22 Flamel Tech Sa ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF A PLURALITY OF MICROCAPSULES FOR PROLONGED RELEASE OF LOW SOLUBLE ACTIVE (S) PRINCIPLE (S)
DE50207738D1 (en) * 2002-11-27 2006-09-14 Oramon Arzneimittel Gmbh & Co Process for the preparation of pellets containing a tri- or tetracyclic antidepressant and pharmaceutical preparations containing these pellets

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US7906145B2 (en) 2002-04-09 2011-03-15 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
US7910133B2 (en) 2002-04-09 2011-03-22 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
CN1681483B (en) * 2002-07-26 2011-12-28 弗拉梅技术公司 Improved oral microcapsule with low-solubility active component
US8084045B2 (en) 2003-11-21 2011-12-27 Flamel Technologies Pharmaceutical formulations for the prolonged release of active principle(s) and their applications

Also Published As

Publication number Publication date
FR2313915A1 (en) 1977-01-07

Similar Documents

Publication Publication Date Title
JPS5393620U (en)
JPS5369559U (en)
CS178383B1 (en)
CS178378B1 (en)
CS178361B1 (en)
CS177447B1 (en)
CS177434B1 (en)
CS176999B1 (en)
JPS5393794U (en)
CH609020A5 (en)
CH610369A5 (en)
CH598882A5 (en)
CH598954A5 (en)
CH600188A5 (en)
CH600313A5 (en)
CH600371A5 (en)
CH601644A5 (en)
CH603870A5 (en)
CH605333A5 (en)
CH607020A5 (en)
CH607186A5 (en)
CH607249A5 (en)
CH608711A5 (en)
CH598535A5 (en)
CH609213A5 (en)

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
TP Transmission of property